MORI, MATTEO
MORI, MATTEO
Dipartimento di Scienze Farmaceutiche
Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives
2026 M.L. Silva, M. Mori, S. Villa, A. Tresoldi, F. Meneghetti, M.D.L.F. Bispo
Pyrazinamide-derived 1,2,3-triazoles: Antimicrobial evaluation, selective antimycobacterial activity and mechanism of action insights
2026 P. Houngbedji, A. Bachtíková, J. Boháčová, P. Tabarestani, O. Janďourek, K. Konečná, J. Ősterreicher, P. Paterová, M. Novák, P. Bárta, M. Záhorszká, J. Korduláková, M. Mori, F. Meneghetti, J. Zitko
Discovery of Potent Benzoselenazinone-Based DprE1 Inhibitors: A Novel Selenium-Containing Scaffold with Superior Anti-TB Activity and Pharmacokinetic Properties
2026 Y. Liu, X. Xu, C. Mao, B. Wang, M. Cocorullo, A. Tresoldi, M. Mori, B. Wang, Y. Lu, H. Huang, L.R. Chiarelli, P. Li
Structural and Biophysical Characterization of Aminobenzo[d]isothiazole 1,1-Dioxide SOS1 Ligands
2026 T. Moreira Pereira, A. Reyes Romero, M. Van Der Laan, G. Zhirui, R. Oerlemans, M. Groves, M. Mori, F. Meneghetti, A. Dömling
An integrated approach to anti-virulence drug discovery: targeting salicylate synthase in mycobacterial infections
2026 M. Mori, G. Cazzaniga, A. Tresoldi, G. Pianta, A. Griego, E. Scarpa, G. Stelitano, M. Cocorullo, I.L. Batalha, G. Battaglia, L.R. Chiarelli, T. Tuccinardi, M. Bellinzoni, L. Rizzello, E. Pini, S. Villa, F. Meneghetti
Cellulose-Based Nanosponges Loaded with Palladium as Efficient Heterogeneous Catalysts for the Synthesis of Challenging Derivatives with Pharmaceutical Relevance
2025 G. Cazzaniga, G. Nicastro, C. Punta, A. Sacchetti, S. Villa, M. Mori, L. Riva
Repurposing of FDA‐Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach
2025 G. Stelitano, C. Bettoni, M. Mori, M. Cocorullo, A. Tresoldi, F. Meneghetti, S. Villa, L.R. Chiarelli
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy
2025 G. Cazzaniga, M. Mori, A. Griego, E. Scarpa, G. Moschetti, S. Muzzioli, G. Stelitano, L.R. Chiarelli, M. Cocorullo, E. Casali, A. Porta, G. Zanoni, A. Tresoldi, E. Pini, Í.L. Batalha, G. Battaglia, T. Tuccinardi, L. Rizzello, S. Villa, F. Meneghetti
Novel quinazolinones active against multidrug‐resistant Mycobacterium tuberculosis: synthesis, antimicrobial evaluation and in silico exploration of PonA1 as a potential target
2025 M. Kerda, D. Nawrot, P. Slechta, M. Domanský, A. Askari, H. Kamangar, O. Janďourek, K. Konečná, P. Paterová, I. Hlbočanová, M. Macháček, M. Mori, F. Meneghetti, M. Doležal, J. Zitko, G. Bouz
Synthesis and crystallographic investigation of two new neutral Ir(III) complexes bearing 6-(phenyl)phenanthridine ligands
2025 L. Menduti, M. Mori, X. Zhou, N. Quadrio, F. Meneghetti, L. De Cola
Benzyl-N-[4-(2-hydroxyethyl)-1,3-thiazol-2-yl]carbamate
2025 L. Spinelli, M. Mori, L. Fumagalli
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation
2025 M. Mori, E.M.A. Fassi, F. Villa, E.G. Milano, F. Forlani, F. Cappitelli, A. Ratti, F. Meneghetti, G. Roda, G. Grazioso, S. Villa
Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of (E)‐N'‐Benzylidenepyrazine‐2‐Carbohydrazides and their Derivatives
2025 P. Houngbedji, D.E. Nawrot, O. Janďourek, K. Konečná, M. Novák, P. Paterová, P. Bárta, M.H. Rambaher, E. Novotná, C. Castellano, M. Mori, F. Meneghetti, M. Záhorszká, J. Korduláková, J. Zitko
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation
2025 G. Cazzaniga, D. Capelli, R. Montanari, E.M.A. Fassi, G. Grazioso, A. Tresoldi, F. Rinaldi, E. Calleri, I. Bassanini, S. Romeo, M. Garofalo, M. Mori, F. Meneghetti, S. Villa
Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation
2025 M. Lusardi, E. Morretta, A. Spallarossa, M. Chiara Monti, C. Rosano, E. Iervasi, M. Ponassi, M. Mori, F. Meneghetti, C. Brullo
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists
2024 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, E.M.A. Fassi, G. Grazioso, F. Meneghetti, S. Villa
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
2024 M. Mori, M. Cocorullo, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, L.R. Chiarelli, M. Tomaiuolo, P. Delre, G.F. Mangiatordi, M. Garofalo, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Targeting iron acquisition in M. abscessus: a new strategy for the development of anti-virulence agents for cystic fibrosis patients
2024 M. Mori, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, M. Cocorullo, L.R. Chiarelli, P. Delre, G.F. Mangiatordi, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Exploring the Inhibition of Iron Acquisition in M. abscessus as a Potential Anti-Virulence Strategy in People with Cystic Fibrosis
2024 M. Mori, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, M. Cocorullo, L.R. Chiarelli, P. Delre, G.F. Mangiatordi, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
A hit expansion of 3-benzamidopyrazine-2-carboxamide: Toward inhibitors of prolyl-tRNA synthetase with antimycobacterial activity
2024 V. Sukanth Kumar Pallabothula, N. Taimur Abdalrahman, M. Mori, A. Hossein Fekri, O. Janďourek, K. Konečná, P. Paterová, M. Novák, P. Dudášová-Hatoková, P. Štěrbová-Kovaříková, C. Castellano, F. Meneghetti, S. Villa, J. Kuneš, M. Juhás, J. Zitko